SCHEMBL6427237

SCHEMBL6427237

CCCCCCCCCCCCCCCCOS(=O)(=O)C(F)(F)F

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 10/20 0.55
CA2 P00918 10/20 0.55
CA9 Q16790 8/20 0.55
CA12 O43570 3/20 0.55
CA7 P43166 3/20 0.55
CA14 Q9ULX7 3/20 0.55
CA3 P07451 2/20 0.55
CA4 P22748 2/20 0.55
CA6 P23280 2/20 0.55
CA5A P35218 2/20 0.55
CA5B Q9Y2D0 2/20 0.55
RECQL P46063 2/20 0.53
GLA P06280 1/20 0.53
HPGD P15428 1/20 0.53
TSHR P16473 1/20 0.53
MAPK1 P28482 1/20 0.53
EPHX2 P34913 1/20 0.53
BLM P54132 1/20 0.53
EPHX1 P07099 1/20 0.46
CES2 O00748 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30609754 1.00 CA1 (0.55) CA1CA2CA9CA12CA7
SCHEMBL7556918 1.00 CA1 (0.55) CA1CA2CA9CA12CA7
SCHEMBL2309725 1.00 CA1 (0.55) CA1CA2CA9CA12CA7
SCHEMBL18476009 1.00 CA1 (0.55) CA1CA2CA9CA12CA7
SCHEMBL8376368 1.00 CA1 (0.55) CA1CA2CA9CA12CA7
SCHEMBL902041 1.00 CA1 (0.55) CA1CA2CA9CA12CA7
SCHEMBL1744340 1.00 CA1 (0.55) CA1CA2CA9CA12CA7
SCHEMBL12649167 1.00 CA1 (0.55) CA1CA2CA9CA12CA7
SCHEMBL7563627 1.00 CA1 (0.55) CA1CA2CA9CA12CA7
SCHEMBL4338731 1.00 CA1 (0.55) CA1CA2CA9CA12CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118652295-A Preparation method of 2' -hexadecyloxy guanosine derivative 安徽美华高科制药有限公司 2024-09-17 CN claimed
CN-118652295-A Preparation method of 2' -hexadecyloxy guanosine derivative 安徽美华高科制药有限公司 2024-09-17 CN disclosed
US-20230321226-A1 SYNTHETIC ARCHAEAL DIETHER LIPIDS APHP (ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS) (FR) 2023-10-12 US disclosed
EP-3468566-A1 SYNTHETIC LIPID ARCHAEUM DIETHERS Sorbonne Universite (FR) 2019-04-17 EP disclosed
WO-2017212197-A1 SYNTHETIC LIPID ARCHAEUM DIETHERS UNIVERSITÉ PIERRE ET MARIE CURIE - PARIS 6 (UPMC) (FR) 2017-12-14 WO disclosed
US-20050244807-A1 Two-photon absorption heteroaromatic chromophores and compositions thereof UNIVERSTA' DEGLI STUDI DI MILANO-BICOCCA (IT) 2005-11-03 US disclosed
EP-1534702-A1 TWO-PHOTON ABSORPTION HETEROAROMATIC CHROMOPHORES AND COMPOSITIONS THEREOF Universita' Degli Studi Di Milano - Bicocca (IT) 2005-06-01 EP disclosed
WO-2004018456-A1 TWO-PHOTON ABSORPTION HETEROAROMATIC CHROMOPHORES AND COMPOSITIONS THEREOF UNIVERSITA' DEGLI STUDI DI MILANO - BICOCCA (IT) 2004-03-04 WO disclosed
WO-2002072068-A2 LIPIDS, LIPID COMPOSITIONS, LIPOSOMES, AND LIPOPLEXES CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2002-09-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230321226-A1 SYNTHETIC ARCHAEAL DIETHER LIPIDS DDOST, ABHD16A, GMDS CA1 2903/4885CA2 4219/4885CA9 4238/4885
US-20050244807-A1 Two-photon absorption heteroaromatic chromophores and compositions thereof CRY2, ARNT, DCX CA1 3756/4885CA2 991/4885CA9 1140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.